Histone demethylase lysine demethylase 5B in development and cancer-Reference-Cited by-同舟云学术

Histone demethylase lysine demethylase 5B in development and cancer

Published:2016-12-10 Issue:5 Volume:8 Page:8980-8991
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Han Mengjiao¹,Xu Wenxia¹,Cheng Pu²,Jin Hongchuan¹,Wang Xian¹

Affiliation:

1. Department of Medical Oncology, Key Laboratory of Biotherapy in Zhejiang, Sir Runrun Shaw Hospital, Medical School of Zhejiang University, China

2. Department of Surgical Oncology, Key Laboratory of Cancer Prevention & Intervention, National Ministry of Education, Provincial Key Laboratory of Molecular Biology in Medical Sciences, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co‐targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis;The Prostate;2024-04-11

2. The KDM5 inhibitor PBIT reduces proliferation of castration-resistant prostate cancer cells via cell cycle arrest and the induction of senescence;Experimental Cell Research;2024-04

3. Alcohol-induced epigenetic changes prevent fibrosis resolution after alcohol cessation in miceresolution;Hepatology;2023-11-09

4. MicroRNA-Mediated Regulation of Histone-Modifying Enzymes in Cancer: Mechanisms and Therapeutic Implications;Biomolecules;2023-10-28

5. Tumour follower cells: A novel driver of leader cells in collective invasion (Review);International Journal of Oncology;2023-08-22